Correction to: Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK‑3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high‑fat dietstreptozocin rat model
Crossref DOI link: https://doi.org/10.1007/s00424-024-02959-4
Published Online: 2024-04-05
Published Print: 2024-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Moghazy, Hoda M.
Abdelhaliem, Nesreen G
Mohammed, Sherine Ahmed
Hassan, Asmaa
Abdelrahman, Amany http://orcid.org/0000-0003-1909-242X
Text and Data Mining valid from 2024-04-05
Version of Record valid from 2024-04-05
Article History
First Online: 5 April 2024